HealthEquity (HQY) Stock Price, News & Analysis

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HQY shares.
View HQY analyst ratings or view top-rated stocks.

11 brokerages have issued twelve-month price objectives for HealthEquity's stock. Their HQY share price targets range from $72.00 to $110.00. On average, they expect the company's share price to reach $96.17 in the next twelve months. This suggests a possible upside of 20.4% from the stock's current price.
View analysts price targets for HQY or view top-rated stocks among Wall Street analysts.

HealthEquity's stock was trading at $66.30 at the beginning of the year. Since then, HQY shares have increased by 20.4% and is now trading at $79.85.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, June 3rd 2024.
View our HQY earnings forecast.

HealthEquity, Inc. (NASDAQ:HQY) released its quarterly earnings data on Tuesday, March, 19th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.08. The firm had revenue of $262.39 million for the quarter, compared to analysts' expectations of $258.56 million. HealthEquity had a net margin of 5.57% and a trailing twelve-month return on equity of 6.91%.

ETFs with the largest weight of HealthEquity (NASDAQ:HQY) stock in their portfolio include Aztlan Global Stock Selection DM SMID ETF (AZTD), Motley Fool Small-Cap Growth ETF (TMFS), MFAM Small-Cap Growth ETF (MFMS), Motley Fool Mid-Cap Growth ETF (TMFM), SPDR S&P Health Care Services ETF (XHS), Global X FinTech Thematic ETF (FINX), Nuveen Small Cap Select ETF (NSCS) and Putnam Sustainable Future ETF (PFUT).

HealthEquity updated its FY 2025 earnings guidance on Thursday, April, 11th. The company provided earnings per share (EPS) guidance of 2.790-2.960 for the period, compared to the consensus EPS estimate of 2.830. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

HealthEquity's stock is owned by a number of retail and institutional investors. Top institutional investors include Wasatch Advisors LP (8.64%), Allspring Global Investments Holdings LLC (1.30%), Vaughan Nelson Investment Management L.P. (0.71%), Inspirion Wealth Advisors LLC (0.09%), Los Angeles Capital Management LLC (0.04%) and State of Michigan Retirement System (0.02%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Evelyn S Dilsaver, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten.
View institutional ownership trends.

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.